# Combination Therapy of F8IL10 and Methotrexate in Rheumatoid Arthritis Patients

> **NCT02076659** · PHASE1 · COMPLETED · sponsor: **Philogen S.p.A.** · enrollment: 36 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** F8IL10
- **DRUG:** Methotrexate

## Key facts

- **NCT ID:** NCT02076659
- **Lead sponsor:** Philogen S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2017-04
- **Final completion:** 2017-04-13
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2018-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02076659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02076659, "Combination Therapy of F8IL10 and Methotrexate in Rheumatoid Arthritis Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02076659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*